Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$4,158,862 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Derivatives in LXRX
reported options exposure · as of Jun 30, 2026CallValue
$1,398,960
CallShares
582,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in LXRX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,398,960 | 582,900 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $871,260 | 558,500 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $4,158,862 | 2,665,938 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $22,620 | 14,500 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $1,982,948 | 1,724,304 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $119,715 | 104,100 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $15,255 | 11,300 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $616,314 | 456,530 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $59,470 | 62,600 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $764,433 | 804,667 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $162,995 | 220,264 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $134,016 | 85,361 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $218,157 | 129,856 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $675,811 | 281,588 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $416,719 | 272,367 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $89,303 | 81,930 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $47,054 | 20,548 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $105,760 | 43,523 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $33,101 | 17,331 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $82,898 | 34,541 | Shares | Defined | 2022-11-15 | |
| 2022-03-31 | $41,220 | 19,723 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $39,400 | 10,000 | Call | Defined | 2022-02-15 | |
| 2021-12-31 | $151,559 | 38,467 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $72,631 | 15,100 | Call | Defined | 2021-11-16 | |
| 2021-09-30 | $191,053 | 39,720 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $95,013 | 20,700 | Put | Defined | 2021-08-16 | |
| 2021-06-30 | $69,817 | 15,211 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $133,108 | 22,676 | Shares | Defined | 2021-05-18 | |
| 2020-09-30 | $17,295 | 12,011 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $36,294 | 18,147 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||